Validation of the Cervicothoracic Differentiation Test
- Disease/Condition
- Neck Pain
- Drug/Device/Intervention
- spinal manipulation
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- University of Hartford
- Location
- West Hartford, United States of America
- Phase
- N/A
- Start date
- Feb 20, 2024
- End date
- Feb 01, 2025
- Enrollment
- 40 participants
pain with motion
The goal of this clinical trial is to compare the effects of two spinal manipulations in
 adults between the ages of 18-65 based on the results of a non-invasive clinical test. The
 main question it aims to answer is: • Does matched or unmatched region of manipulation based
 on the CTDT result in greater reduction of pain levels and improvement in range of motion in
 adults with neck pain compared to unmatched manipulations? Participants will be asked to:
 
 - rate their pain with neck movement, complete brief questionnaires about their pain,
 
 - have their neck range of motion measured,
 
 - perform a test known as the cervico-thoracic differentiation test (CTDT),
 
 - receive either a cervical or thoracic manipulation,
 
 - repeat the range of motion measurements.
 
 - A second session will occur 7-10 days later where questionnaires and range of motion
 measures will be repeated.
 
 Researchers will compare the effects of manipulation matched to CTDT test result to
 individuals in the unmatched CTDT manipulation group to see if the CTDT may indicate which
 region will provide a greater treatment effect for individuals with neck pain.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06287242
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06287242 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Hartford and is currently Recruiting. The study focuses on Neck Pain. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.